HR001124S0032_Attachment_C_Proposal_Summary_Slide_Template.pptx

This document is a proposal summary slide template for the Broad-Spectrum Antagonists For Editors (B-SAFE) federal grant opportunity (Solicitation Number: HR001124S0032) from the Defense Advanced Research Projects Agency (DARPA).

The B-SAFE program is seeking proposals for novel molecules that inhibit CRISPR-Cas gene editing processes. Proposals should describe the need, problem, goal, new ideas, and existing approaches/state-of-the-art. DARPA is also interested in methods to rapidly discover inhibitors for emerging gene editing technologies beyond CRISPR-Cas. The program will assess inhibitor activity in vitro, with top performing molecules selected for scale-up and evaluation by Department of Defense stakeholders. The federal grant program under which this opportunity is assigned is the Research and Technology Development program (CFDA 12.910).